News
34mon MSN
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...
The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...
The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
Advisers to the U.S. Food and Drug Administration will discuss recommendations for updated COVID-19 vaccines ahead of the ...
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...
The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over ...
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans — a move that will limit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results